Q’Apel Medical, a developer of devices for neurovascular intervention, announced the United States launch of the Lynx a ...

Abbott’s TactiFlex Duo dual-energy, sensor-enabled ablation catheter treats patients with difficult atrial fibrillation (AFib ...

Catheter ablation for atrial fibrillation (AF) did not significantly improve AF-related quality of life compared with a sham ...

Patients with challenging cases of atrial fibrillation (AFib) have a new treatment option now that the FDA has approved ...

Q'Apel Medical (Q'Apel), an innovator in neurovascular intervention, today announced the U.S. launch of the Lynx™ Aspiration Catheter System, an advanced family of catheters that supports physicians ...

In patients with atrial fibrillation, catheter ablation did not improve quality of life at 6 months compared with a sham ...

FDA clearance for Abbott’s TactiFlex Duo follows the dual ablation catheter’s receipt of a European CE mark in January 2026.

It was a relatively small study, and patients were only followed for six months, but these late-breaking data out of ESC ...

Whether catheter-directed thrombolysis improves clinical outcomes in patients with intermediate-high–risk pulmonary embolism, ...

The Liv Pre-lubricated Intermittent Catheter provides features for hygienic self-catheterisation and catheter protection ...

Boston Scientific recalled and will discontinue all Imager II angiographic catheters due to a manufacturing issue.

Catheter ablation for atrial fibrillation (AF) did not significantly improve AF-related quality of life compared with a sham ...